Itau Unibanco Holding S.A. Veracyte, Inc. Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $867 - $1,261	-44 Reduced 22.56%	151 $4,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $66 - $89	3 Added 1.56%	195 $4,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $3,793 - $4,885	-181 Reduced 48.53%	192 $4,000
Q4 2022 Feb 09, 2023	BUY	$15.31 - $29.94 $5,710 - $11,167	373 New	373 $8,000
Q2 2022 Aug 15, 2022	SELL	$15.45 - $29.52 $6,473 - $12,368	-419 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $372 - $722	17 Added 4.23%	419 $12,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $14,508 - $21,623	402 New	402 $17,000

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.